UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 370

Sortiert nach

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.617-627

2017

Volltextzugriff (PDF)

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

Alimentary pharmacology & therapeutics, 2017-12, Vol.46 (11-12), p.1054-1060

2017

Volltextzugriff (PDF)

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Gut, 2006-03, Vol.55 (3), p.403-408

2006

Volltextzugriff (PDF)

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

Journal of viral hepatitis, 2012-04, Vol.19 (4), p.244-253

2012

Volltextzugriff (PDF)

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (7), p.991-1003

2017

Volltextzugriff (PDF)

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.733-739

2007

Volltextzugriff (PDF)

Evidence of Viral Replication in Circulating Dendritic Cells during Hepatitis C Virus Infection

The Journal of infectious diseases, 2003-06, Vol.187 (12), p.1951-1958

2003

Volltextzugriff (PDF)

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Journal of hepatology, 2017, Vol.66 (1), p.S669-S670

2017

Volltextzugriff (PDF)

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Clinical chemistry (Baltimore, Md.), 2007-09, Vol.53 (9), p.1615-1622

2007

Volltextzugriff (PDF)

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.979-988

2013

Volltextzugriff (PDF)

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Journal of viral hepatitis, 2007-07, Vol.14 (7), p.460-467

2007

Volltextzugriff (PDF)

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Journal of hepatology, 2016, Vol.64 (2), p.S736-S737

2016

Volltextzugriff (PDF)

Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection

Journal of hepatology, 2017, Vol.66 (1), p.S299-S300

2017

Volltextzugriff (PDF)

Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation

Transplant infectious disease, 2013-12, Vol.15 (6), p.E211-E215

2013

Volltextzugriff (PDF)

Performance of FibroScan® to detect large esophageal varices in chronic liver diseases is improved by a novel spleen-dedicated examination

Journal of hepatology, 2017, Vol.66 (1), p.S374-S374

2017

Volltextzugriff (PDF)

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

Journal of hepatology, 2011-03, Vol.54, p.S130-S130

2011

Volltextzugriff (PDF)

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

Journal of hepatology, 2015-04, Vol.62, p.S247-S248

2015

Volltextzugriff (PDF)

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Journal of hepatology, 2015-04, Vol.62, p.S213-S214

2015

Volltextzugriff (PDF)

Controlled attenuation parameter predicts steatosis in alcoholic liver disease and correlates with poor metabolic phenotype and cardiovascular risk: a biopsy-controlled multicenter study

Journal of hepatology, 2017, Vol.66 (1), p.S665-S665

2017

Volltextzugriff (PDF)

Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis

Journal of hepatology, 2017, Vol.66 (1), p.S69-S69

2017

Volltextzugriff (PDF)

FibroScan-based score to identify patients with non-alcoholic steatohepatitis: development in a multi-centric British cohort and validation in a large American cohort

Journal of hepatology, 2017, Vol.66 (1), p.S66-S67

2017

Volltextzugriff (PDF)

Retreatment with Direct Active Antivirals of genotype 1, 3 and 4 chronic hepatitis C patients who previously failed an anti-NS5A-containing regimen in real world

Journal of hepatology, 2017, Vol.66 (1), p.S730-S731

2017

Volltextzugriff (PDF)

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Journal of hepatology, 2017, Vol.66 (1), p.S161-S162

2017

Volltextzugriff (PDF)

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab

Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (6), p.714-721

2011

Volltextzugriff (PDF)

On Treatment HCV RNA as a Predictor of SVR12 in Patients with Genotype 1–6 HCV Infection Treated with Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks: An Analysis of the Astral-1, Astral-2, and Astral-3 Studies

Journal of hepatology, 2016, Vol.64 (2), p.S817-S817

2016

Volltextzugriff (PDF)

1 – 25 von 370

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(314)
Mit Volltextzugriff
(342)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(112)
Life Sciences & Biomedicine
(107)
Science & Technology
(107)
Gastroenterology And Hepatology
(93)
Male
(82)
Gastroenterology & Hepatology
(78)
Female
(77)
Middle Aged
(73)
Adult
(71)
Life Sciences
(51)
Biological And Medical Sciences
(49)
Medical Sciences
(48)
Aged
(42)
Gastroenterology. Liver. Pancreas. Abdomen
(32)
Infectious Diseases
(30)
Hepatitis C Virus
(27)
Prospective Studies
(27)
Hepatitis C
(26)
Liver Cirrhosis - Diagnosis
(26)
Fibrosis
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

Evidence of Viral Replication in Circulating Dendritic Cells during Hepatitis C Virus Infection

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection

Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation

Performance of FibroScan® to detect large esophageal varices in chronic liver diseases is improved by a novel spleen-dedicated examination

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Controlled attenuation parameter predicts steatosis in alcoholic liver disease and correlates with poor metabolic phenotype and cardiovascular risk: a biopsy-controlled multicenter study

Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis

FibroScan-based score to identify patients with non-alcoholic steatohepatitis: development in a multi-centric British cohort and validation in a large American cohort

Retreatment with Direct Active Antivirals of genotype 1, 3 and 4 chronic hepatitis C patients who previously failed an anti-NS5A-containing regimen in real world

The combination of Fibroscan with blood markers in the fibrometerVCTE significantly reduces the use of liver biopsy for the assessment of advanced fibrosis in non-alcoholic fatty liver disease

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab

On Treatment HCV RNA as a Predictor of SVR12 in Patients with Genotype 1–6 HCV Infection Treated with Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks: An Analysis of the Astral-1, Astral-2, and Astral-3 Studies

Suchergebnisse filtern